News
BNXT BXT BNXTF - BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
Oct 19, 2026 · ThinkSabio Blog
BNXT BXT BNXTF - BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
19-OCT-2026 03:05 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
